Pricing Log in Create free account

Annovis Bio, Inc. (ANVS) vs IRulya Therapeutics Inc. (IRLA)

Annovis Bio, Inc. and IRulya Therapeutics Inc. are both Biotechnology companies. Annovis Bio, Inc. and IRulya Therapeutics Inc. are of similar size ($29.8M and $28.6M). Across the 7 metrics below, IRulya Therapeutics Inc. leads on 5 and Annovis Bio, Inc. on 2.

Valuation

Metric ANVS IRLA Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (218.29%) (463.25%) (32.88%)
Free cash flow yield (140.87%) (25.09%) (23.13%)

Profitability

Metric ANVS IRLA Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (703.68%) 784.09% (51.96%)
Return on assets (227.74%) (76.68%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANVS IRLA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 39.39% (28.24%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANVS IRLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.47 14.52 4.97
Net debt to EBITDA 0.66 0.00 1.01

Dividend

Metric ANVS IRLA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ANVS IRLA Biotechnology median
Market cap 28.55m 29.81m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack